Image Trademark with Serial Number 86605527
Status: 700 - Registered
Serial Number
86605527
Registration Number
5173984
Status
700 - Registered
Status Date
2017-04-04
Filing Date
2015-04-22
Registration Number
5173984
Registration Date
2017-04-04
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s)
Typeset
Design Searches
280103 - Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters.
Published for Opposition Date
2016-12-13
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
LEWIS, SHAILA E
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of two Chinese characters.
Goods and Services
Vitamin preparations; medicines for human purposes for the treatment of Cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergies, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, and adrenocortical insufficiency; capsules for pharmaceutical purposes for the treatment of hypertension, hyperlipidemia, schizophrenia, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystiti; pharmaceutical preparations for the treatment of Cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, chronic congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis and Septicemia, community-acquired pneumonia, urogenital tract infection, endocarditis, bacterial infection, meningitis, and granulocytopenia; chemico-pharmaceutical preparations for the treatment of cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, chronic congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Hematologic Disorders, humanases, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, Lower respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis, bacteremia, community-acquired pneumonia, gynecological infections, urogenital tract infection, endocarditis, bacterial infection,, meningitis, and granulocytopenia; analgesics; drugs for medical purposes for the treatment of cancers, the prevention of organ rejection in renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, Bacterial septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis and Septicemia, bacteremia, community-acquired pneumonia, septicemia, urogenital tract infection, endocarditis, bacterial infection, urinary tract infection, meningitis, granulocytopenia, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency; capsules for medicines sold empty; sedatives; tranquillizers; biological preparations for medical purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; chemical preparations for pharmaceutical purposes for the treatment of cancers, prevention of organ rejection in renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergies, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Community-acquired pneumonia, Nosocomial pneumonia, intra-abdominal infections, Skin and skin structure infections, endocarditis, pneumonia, urinary tract infection, Gynecological infections, meningitis, septicemia, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis; chemical preparations for medical purposes for the treatment of cancers, the prevention of organ rejection in renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergies, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Community-acquired pneumonia, Nosocomial pneumonia, Pseudomonas aeruginosa, Enterococcus faecalis, Staphylococcus aureus, Streptococcus anginosus, Streptococcus intermadius, Streptococcus constellatus, bacteroides fragilis, Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, clostridium perfringens, Peptostreptococcus micros, urogenital tract infection, endocarditis, pneumonia, urinary tract infection, Gynecological infections meningitis, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis; antibiotics; Injectable pharmaceuticals for the treatment of Cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, chronic congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis and Septicemia, community-acquired pneumonia, urogenital tract infection, endocarditis, bacterial infection, meningitis, and granulocytopenia; Bulk drugs, namely, active pharmaceutical preparations for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia; biochemical medicines for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; blood products, namely, blood and blood plasma; Tinctures, namely, pharmaceutical preparations deriving from crude drugs being immersed in alcohol for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; radium for medical purposes; radioactive substances for use in nuclear medicine; isotopes for medical purposes; radioactive substances for medical purposes; oxygen baths preparations for medical use; gases for medical use; oxygen for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants for hygienic purposes; disinfectants; contact lens solution; contact lens cleaning preparations; cleaning solutions for use with contact lenses; bacteriological culture mediums; bouillons for bacteriological cultures; nutritive substances for microorganisms for medical purposes; cultures of microorganisms for medical and veterinary use; dietetic pasta, crackers and sugar for medical use; nutritional supplements; food for babies; infant milk powder; air purifying preparations; disinfectants for chemical toilets; medicines for veterinary purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; biological preparations for veterinary purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; chemical preparations for veterinary purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; dietary supplements for animals; pesticides; vermin destroying preparations; disinfectant wipes; wadding for medical purposes; dental abrasives; dental mastics
Goods and Services
Retail and wholesale store services featuring medicines; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring sanitary preparations
Transliteration Statement
The transliteration of the Chinese characters in the mark is "Hui Zheng." Hui means "brightness" and "Zheng" means "upright."
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-05-01
Primary Code
005
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2015-05-01
Primary Code
035
Current Trademark Owners
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
CATHERINE M.C. FARRELLY
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
China P.Rep. | False | ||
China P.Rep. | False |
Trademark Events
Event Date | Event Description |
2015-04-25 | NEW APPLICATION ENTERED IN TRAM |
2015-05-01 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2015-05-02 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2015-08-01 | ASSIGNED TO EXAMINER |
2015-08-03 | NON-FINAL ACTION WRITTEN |
2015-08-03 | NON-FINAL ACTION E-MAILED |
2015-08-03 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2016-01-29 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2016-01-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2016-01-30 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2016-02-24 | FINAL REFUSAL WRITTEN |
2016-02-24 | FINAL REFUSAL E-MAILED |
2016-02-24 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2016-08-24 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2016-08-24 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2016-08-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2016-09-15 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2016-10-04 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
2016-10-13 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
2016-11-02 | EXAMINERS AMENDMENT -WRITTEN |
2016-11-02 | EXAMINERS AMENDMENT E-MAILED |
2016-11-02 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2016-11-02 | EXAMINER'S AMENDMENT ENTERED |
2016-11-02 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2016-11-23 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2016-12-13 | PUBLISHED FOR OPPOSITION |
2016-12-13 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2017-02-07 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2017-02-17 | TEAS DELETE 1(B) BASIS RECEIVED |
2017-02-27 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2017-02-17 | NOTICE OF ALLOWANCE CANCELLED |
2017-02-28 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
2017-04-04 | REGISTERED-PRINCIPAL REGISTER |
2018-09-19 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
2019-09-27 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |